These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 11407701)

  • 21. Interleukin-17 receptor deficiency results in impaired synovial expression of interleukin-1 and matrix metalloproteinases 3, 9, and 13 and prevents cartilage destruction during chronic reactivated streptococcal cell wall-induced arthritis.
    Koenders MI; Kolls JK; Oppers-Walgreen B; van den Bersselaar L; Joosten LA; Schurr JR; Schwarzenberger P; van den Berg WB; Lubberts E
    Arthritis Rheum; 2005 Oct; 52(10):3239-47. PubMed ID: 16200598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retinoic acid-induced type II collagen degradation does not correlate with matrix metalloproteinase activity in cartilage explant cultures.
    Price JS; Wang-Weigand S; Bohne R; Kozaci LD; Hollander AP
    Arthritis Rheum; 1999 Jan; 42(1):137-47. PubMed ID: 9920024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involvement of matrix metalloproteinases and their inhibitors in peripheral synovitis and down-regulation by tumor necrosis factor alpha blockade in spondylarthropathy.
    Vandooren B; Kruithof E; Yu DT; Rihl M; Gu J; De Rycke L; Van Den Bosch F; Veys EM; De Keyser F; Baeten D
    Arthritis Rheum; 2004 Sep; 50(9):2942-53. PubMed ID: 15457463
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oncostatin M induces angiogenesis and cartilage degradation in rheumatoid arthritis synovial tissue and human cartilage cocultures.
    Fearon U; Mullan R; Markham T; Connolly M; Sullivan S; Poole AR; FitzGerald O; Bresnihan B; Veale DJ
    Arthritis Rheum; 2006 Oct; 54(10):3152-62. PubMed ID: 17009243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Scavenger receptor class A type I/II determines matrix metalloproteinase-mediated cartilage destruction and chondrocyte death in antigen-induced arthritis.
    van Lent PL; Hofkens W; Blom AB; Grevers L; Sloetjes A; Takahashi N; van Tits LJ; Vogl T; Roth J; de Winther MP; van den Berg WB
    Arthritis Rheum; 2009 Oct; 60(10):2954-65. PubMed ID: 19790077
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of inhibition of matrix metalloproteinases on cartilage loss in vitro and in a guinea pig model of osteoarthritis.
    Sabatini M; Lesur C; Thomas M; Chomel A; Anract P; de Nanteuil G; Pastoureau P
    Arthritis Rheum; 2005 Jan; 52(1):171-80. PubMed ID: 15641085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relative contribution of matrix metalloprotease and cysteine protease activities to cytokine-stimulated articular cartilage degradation.
    Sondergaard BC; Henriksen K; Wulf H; Oestergaard S; Schurigt U; Bräuer R; Danielsen I; Christiansen C; Qvist P; Karsdal MA
    Osteoarthritis Cartilage; 2006 Aug; 14(8):738-48. PubMed ID: 16563811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.
    Fraser A; Fearon U; Billinghurst RC; Ionescu M; Reece R; Barwick T; Emery P; Poole AR; Veale DJ
    Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assays of proteoglycan and collagen degradation in cultures of rabbit cartilage explants.
    Lesur C; Sabatini M
    Methods Mol Med; 2004; 100():219-36. PubMed ID: 15280598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of cartilage matrix metalloproteinases by activated protein C.
    Jackson MT; Smith MM; Smith SM; Jackson CJ; Xue M; Little CB
    Arthritis Rheum; 2009 Mar; 60(3):780-91. PubMed ID: 19248107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of matrix metalloproteinases in articular cartilage of temporomandibular and knee joints of mice during growth, maturation, and aging.
    Gepstein A; Shapiro S; Arbel G; Lahat N; Livne E
    Arthritis Rheum; 2002 Dec; 46(12):3240-50. PubMed ID: 12483728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Matrix metalloproteinases and inhibitor in knee synovial fluid as cartilage biomarkers in rabbits: the effect of high-intensity jumping exercise.
    Qi C; Changlin H; Zefeng H
    J Surg Res; 2007 Jun; 140(1):149-57. PubMed ID: 17397871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MMP protein and activity levels in synovial fluid from patients with joint injury, inflammatory arthritis, and osteoarthritis.
    Tchetverikov I; Lohmander LS; Verzijl N; Huizinga TW; TeKoppele JM; Hanemaaijer R; DeGroot J
    Ann Rheum Dis; 2005 May; 64(5):694-8. PubMed ID: 15834054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of furin-like enzymes blocks interleukin-1alpha/oncostatin M-stimulated cartilage degradation.
    Milner JM; Rowan AD; Elliott SF; Cawston TE
    Arthritis Rheum; 2003 Apr; 48(4):1057-66. PubMed ID: 12687549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insights from a novel three-dimensional in vitro model of lyme arthritis: standardized analysis of cellular and molecular interactions between Borrelia burgdorferi and synovial explants and fibroblasts.
    Franz JK; Fritze O; Rittig M; Keysser G; Priem S; Zacher J; Burmester GR; Krause A
    Arthritis Rheum; 2001 Jan; 44(1):151-62. PubMed ID: 11212153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activated gelatinase-B (MMP-9) and urokinase-type plasminogen activator in synovial fluids of patients with arthritis. Correlation with clinical and experimental variables of inflammation.
    Koolwijk P; Miltenburg AM; van Erck MG; Oudshoorn M; Niedbala MJ; Breedveld FC; van Hinsbergh VW
    J Rheumatol; 1995 Mar; 22(3):385-93. PubMed ID: 7783051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MAPKs are essential upstream signaling pathways in proteolytic cartilage degradation--divergence in pathways leading to aggrecanase and MMP-mediated articular cartilage degradation.
    Sondergaard BC; Schultz N; Madsen SH; Bay-Jensen AC; Kassem M; Karsdal MA
    Osteoarthritis Cartilage; 2010 Mar; 18(3):279-88. PubMed ID: 19932675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Repeated detection of Borrelia burgdorferi DNA in synovial fluid of a child with Lyme arthritis.
    Karch H; Huppertz HI
    Rheumatol Int; 1993; 12(6):227-9. PubMed ID: 8484094
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lyme arthritis in children and adolescents: outcome 12 months after initiation of antibiotic therapy.
    Bentas W; Karch H; Huppertz HI
    J Rheumatol; 2000 Aug; 27(8):2025-30. PubMed ID: 10955347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Borrelia burgdorferi in Lyme arthritis and undifferentiated arthritis.
    Jaulhac B; Sibilia J; Pourel J; Kuntz JL
    Rev Rhum Engl Ed; 1999 Jan; 66(1 Suppl):20S-22S. PubMed ID: 10063519
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.